EVO ICL vs LASIK in 2026: The High-Myopia Decision

For prescriptions LASIK can’t safely reach, for corneas too thin for laser correction, and for patients who want a reversible procedure — EVO ICL is the answer. For everyone else, LASIK is faster, cheaper, and equally proven. Here’s the honest breakdown.

Why this comparison matters

EVO ICL and LASIK solve the same problem — correcting refractive error — using entirely different mechanisms. LASIK reshapes the cornea. EVO ICL implants a soft biocompatible lens in front of your natural lens, leaving the cornea untouched. They’re not usually direct competitors: they compete for a specific patient segment where both could work, and where the choice comes down to prescription range, corneal thickness, dry-eye history, and personal preference for a reversible procedure.

For very high myopia (over -8 D), thin corneas, or patients ineligible for corneal laser correction, EVO ICL isn’t really a choice — it’s the answer. For standard prescriptions with normal corneas, LASIK is faster, cheaper, and has decades of long-term outcome data. The middle is where this article lives.

What each procedure actually is

LASIK reshapes the cornea using two lasers — a femtosecond laser to create a flap, then an excimer laser to reshape the underlying tissue. The reshaped cornea bends incoming light differently, correcting focus. Recovery is fast (24 hours), the procedure is well-understood over 25+ years of clinical use, and the corneal changes are permanent.

EVO ICL is an intraocular procedure. A soft, flexible collamer lens (a collagen-copolymer material) is folded, inserted through a small corneal incision, and positioned in front of the natural lens, behind the iris. It sits there permanently, functioning like a permanent contact lens inside the eye. The cornea is unchanged. If needed, the ICL is removable — the procedure is reversible in a way LASIK is not.

Who each is best for

LASIK is best for: patients with prescriptions in the -0.5 to -8 D range, astigmatism up to -6 D, adequate corneal thickness (typically 500+ microns), normal corneal topography, and stable prescription. This covers the majority of refractive candidates. LASIK is faster, cheaper, and has an unmatched long-term outcome database.

EVO ICL is best for: patients with prescriptions beyond -8 D (and up to -20 D in some cases), thin corneas that can’t safely accommodate LASIK ablation, patients with keratoconus concerns or irregular topography, severe baseline dry eye, and patients who value the reversibility of the procedure. For a -10 D patient with 480-micron corneas, EVO ICL isn’t a preference — it’s the appropriate procedure.

Recovery reality

LASIK recovery is faster: visual clarity by 24 hours, back at work the next day for most patients. First-night discomfort is real but brief. Full stabilization takes 4–6 weeks.

EVO ICL recovery is nearly as fast: most patients see well by 24 hours after surgery, though visual clarity can fluctuate for the first week as the eye adjusts to the implant. Post-op steroid and antibiotic drops are used for 2–4 weeks. Because the procedure is intraocular rather than corneal, there’s no dry-eye recovery period — the tear film is unaffected. That’s a real advantage for dry-eye patients.

Cost across destinations

EVO ICL costs meaningfully more than LASIK at every destination — typically 3 to 4 times the price. Colombia’s EVO ICL runs $3,800–$4,800 vs LASIK at $1,000–$1,400. Turkey’s runs $4,200–$5,200 vs LASIK at $1,200–$1,800. The cost premium reflects the actual lens (a single ICL is a substantial cost input), the intraocular surgical complexity, and the specialized surgeon skill required.

The cost premium is worth it when you need what EVO ICL specifically does — correction beyond LASIK’s range, corneal preservation, dry-eye friendliness, reversibility. It’s not worth it as a preference-based upgrade for a standard LASIK candidate. Both procedures at reputable clinics deliver excellent outcomes for their target patient profiles.

Risks and honest downsides of each

LASIK’s risks: dry eye (typically first 3–6 months, often permanent for a subset), flap complications (dislocation, epithelial ingrowth), starbursts and halos at night (usually improving), and permanent corneal thinning. Enhancement is available if regression occurs.

EVO ICL’s risks are different in shape: cataract acceleration (uncommon but real, related to lens sizing and positioning), elevated intraocular pressure requiring management, endothelial cell loss over time (typically small but monitored), and rare cases of pigment dispersion. The procedure is more invasive than LASIK — it’s intraocular surgery — and carries the corresponding rare risks of intraocular procedures. The upside: the cornea is preserved entirely, dry eye risk is negligible, and the procedure is reversible if needed.

Where they overlap and where they diverge

The overlap zone: patients with prescriptions in the -6 to -8 D range with adequate corneal thickness. Both procedures deliver excellent outcomes here, and the choice comes down to dry-eye baseline, reversibility preference, and cost tolerance.

The divergence: patients beyond -8 D or with thin corneas belong in EVO ICL territory; patients under -6 D with normal corneas belong in LASIK territory. Trying to force LASIK on a marginal cornea to save cost is genuinely dangerous. Trying to use EVO ICL on a standard LASIK candidate is overkill and burns money.

The verdict: which one is right for you

Choose LASIK if your prescription is under -8 D, your corneas have adequate thickness (500+ microns typically), and you don’t have severe baseline dry eye. LASIK is faster, cheaper, and has 25+ years of long-term outcome data. It’s the appropriate default for standard refractive candidates.

Choose EVO ICL if your prescription is beyond -8 D, your corneas are too thin for safe LASIK ablation, you have severe baseline dry eye, you have irregular corneal topography, or you value the reversibility of the procedure. For these patients, EVO ICL isn’t an upgrade — it’s the appropriate procedure.

The trap to avoid: don’t let a clinic push you toward the cheaper procedure if your anatomy indicates the more expensive one. A -10 D patient with 480-micron corneas needs EVO ICL, full stop. A -3 D patient with 550-micron corneas is a LASIK candidate, and paying 3–4x for EVO ICL buys reversibility they’ll almost certainly never use.